Harvard Bioscience Acquires Amersham s 1D Products Business for $5.3M | GenomeWeb

Harvard Bioscience has acquired certain assets of Amersham Biosciences’ 1D electrophoresis business, including the Hoefer brand name, for approximately $5.3 million in cash, the companies announced this week. Amersham will retain its 2D gel product lines, which include the Multiphor, IPGPhor, and DALT systems and consumables; and the Ettan 2D gel analysis software. These products will continue to be sold under the Amersham brand name.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.